| 标题 |
And Still They Come Over Troubled Waters: Can Asia’s Third-Generation EGFR Tyrosine Kinase Inhibitors (Furmonertinib, Aumolertinib, Rezivertinib, Limertinib, Befotertinib, SH-1028, and Lazertinib) Affect Global Treatment of EGFR+ NSCLC |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Thoracic Oncology 作者:Sally C.M. Lau; Sai-Hong Ignatius Ou 出版日期:2022-10-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)